Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by chrispion Jul 09, 2021 8:54am
167 Views
Post# 33520347

RE:RE:RE:Disappointing response by the market

RE:RE:RE:Disappointing response by the market
MBT123 wrote: Well at least this management consistent with all the failures before...Every single NR finishes in the RED! Different month different year same results! Thought Rice Krispie would have bought another 200k shares at market with this news?  But again the "market" who is all that matters just doesn't understand? Mmmm a lot smart people read this one and every other NR and turned there nose up at it! Good job DR.R and JD keep pumping these out!


Glad to have you back doing what you do best MBT123.
I knew you wouldn't miss an opportunity to bash the company.

These are the last trades of the day that left us "in the red":

Time ET Ex Price Change Volume Buyer Seller Markers
15:59:37 V 0.38 -0.005 146 80 National Bank 59 PI  
15:59:37 V 0.38 -0.005 200 7 TD Sec 59 PI  
15:59:37 V 0.38 -0.005 2,500 7 TD Sec 1 Anonymous K
15:59:37 V 0.38 -0.005 4,000 22 Fidelity 1 Anonymous K
15:58:45 M 0.39 0.005 3 80 National Bank 7 TD Sec
 

So, with 23 seconds left in the trading day 2 sellers (at the exact same time mind you so it might have actually been one seller) decide to sell 6,846 shares for a total of $2,601 which brings us into the red and you then consider the press release a total failure. Heck, maybe the seller was you just so you could "shove it to the company" and have something to negatively post about (again).

Sometimes it takes more than a day for people to digest the news ;) ... especially during the summer holiday season. But more importantly than the market realizing, or not, the importance and significance of this successful study, is that our current and future partners are now aware of it. That will help licensing negotiations with current and future partners!
 


<< Previous
Bullboard Posts
Next >>